Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 07:47 am Purchase | 2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | RTW Investments, LP | 5,315,514 9.200% | 1,723,528 (+47.98%) | Filing History |
| 2024-02-14 07:46 am Purchase | 2023-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | RTW Investments, LP | 6,887,086 8.400% | 6,887,086 (New Position) | Filing History |
| 2024-02-14 07:44 am Purchase | 2023-12-31 | 13G | Stoke Therapeutics, Inc. STOK | RTW Investments, LP | 4,131,045 9.300% | 260,064 (+6.72%) | Filing History |
| 2024-02-14 07:42 am Purchase | 2023-12-31 | 13G | Vericel Corporation VCEL | RTW Investments, LP | 3,212,794 6.700% | 112,890 (+3.64%) | Filing History |
| 2024-02-14 07:40 am Purchase | 2023-12-31 | 13G | Establishment Labs Holdings Inc. ESTA | RTW Investments, LP | 2,494,138 9.700% | 120,000 (+5.05%) | Filing History |
| 2024-02-14 07:38 am Purchase | 2023-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | RTW Investments, LP | 3,463,201 6.300% | 378,986 (+12.29%) | Filing History |
| 2024-02-14 07:35 am Sale | 2023-12-31 | 13G | C4 Therapeutics, Inc. CCCC | RTW Investments, LP | 0 0.000% | -2,819,472 (Position Closed) | Filing History |
| 2024-02-14 07:34 am Sale | 2023-12-31 | 13G | BrainsWay Ltd. BWAY | RTW Investments, LP | 0 0.000% | -3,204,762 (Position Closed) | Filing History |
| 2024-02-14 07:32 am Sale | 2023-12-31 | 13G | Apyx Medical Corporation APYX | RTW Investments, LP | 1,025,963 3.000% | -2,372,316 (-69.81%) | Filing History |
| 2024-02-14 07:31 am Sale | 2023-12-31 | 13G | Adicet Bio, Inc. ACET | RTW Investments, LP | 258,414 9.600% | -6,678 (-2.52%) | Filing History |
| 2024-02-14 07:29 am Sale | 2023-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA | RTW Investments, LP | 0 0.000% | -2,458,750 (Position Closed) | Filing History |
| 2024-02-14 07:28 am Purchase | 2023-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | RTW Investments, LP | 3,152,341 9.500% | 604,216 (+23.71%) | Filing History |
| 2024-02-14 07:26 am Purchase | 2023-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | RTW Investments, LP | 4,489,596 9.500% | 1,509,114 (+50.63%) | Filing History |
| 2024-02-14 07:13 am Purchase | 2023-12-31 | 13G | PTC Therapeutics, Inc. PTCT | RTW Investments, LP | 7,423,970 9.800% | 1,808,583 (+32.21%) | Filing History |
| 2024-02-14 07:12 am Purchase | 2023-12-31 | 13G | Exagen Inc. XGN | RTW Investments, LP | 1,504,602 8.800% | 140,266 (+10.28%) | Filing History |
| 2024-02-14 07:12 am Sale | 2023-12-31 | 13G | Mirati Therapeutics, Inc. MRTX | RTW Investments, LP | 0 0.000% | -3,643,114 (Position Closed) | Filing History |
| 2024-02-14 07:11 am Purchase | 2023-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | RTW Investments, LP | 9,196,186 9.990% | 3,454,247 (+60.16%) | Filing History |
| 2024-02-14 07:10 am Sale | 2023-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | RTW Investments, LP | 3,354,825 9.990% | -960,277 (-22.25%) | Filing History |
| 2024-02-14 07:10 am Purchase | 2023-12-31 | 13G | 89bio, Inc. ETNB | RTW Investments, LP | 5,578,931 6.000% | 5,578,931 (New Position) | Filing History |
| 2024-02-14 07:09 am Purchase | 2023-12-31 | 13G | Sage Therapeutics, Inc. SAGE | RTW Investments, LP | 5,197,019 8.700% | 5,197,019 (New Position) | Filing History |